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Summary
The physiologic effects of continuous positive airway pressure (CPAP) of 5,10,15, and 20 cm H z 0 during spontaneous ventilation were studied in six anesthetized dogs with simulated respiratory distress syndrome (RDS) induced by iv infusion of oleic acid and in three normal controls. After oleic acid, mean PaOz dropped to 63.6 + 3.1 mm Hg while breathing 100% oxygen and mean shunt fraction was 48.3 f 3.0%. Pa02 and shunt fraction improved significantly at the two highest levels of CPAP (e.g., Pa02 271. 3 + 41.3 mm Hg and shunt fraction 17.8 f 2.2% at 20 cm Hz0 CPAP). Mean mixed venous PO2 rose from 37.4 f 1.5 mm Hg with no CPAP to 60.8 + 3.1 mm Hg at 20 cm H z 0 CPAP. Tissue oxygenation appeared to improve during CPAP, since cardiac output, oxygen delivery, and serum lactate were not significantly affected and mixed venous PO2 rose significantly. However, significant hypoventilation occurred at all but the lowest level of CPAP, mean PaCOz rising from 44.1 f 1.8 mm Hg with no CPAP to 77.6 + 6.8 mm Hg at 20 cm H z 0 CPAP. The hypoventilation during CPAP is consistent with increased work of breathing due to a combination of decreased lung compliance and increased'dead space ventilation due to rapid, shallow breathing.
Speculation
From these studies it appears that CPAP is an effective method of improving tissue oxygenation in severe acute respiratory distress syndromes as previously speculated in clinical studies. Further studies should be directed toward the explanation for the hypoventilation response observed at higher levels of CPAP.
Spontaneous ventilation with continuous positive airway pressure (CPAP) has been widely used in the management of infants with idiopathic RDS because it raises arterial oxygen tension (Pa02) (5, 6) . It has been noted clinically that hypoventilation occurs in patients requiring CPAP during spontaneous ventilation and a causal relationship has been postulated (2, 4). Since CPAP is being used with increasing frequency in all forms of the respiratory distress syndrome, and since other potentially important physiologic consequences of CPAP, e.g., effects on cardiac output and tissue oxygenation, have been evaluated infrequently (1 I), we studied the effects of CPAP on lightly anesthetized dogs with RDS induced by iv infusion of oleic acid. Oleic acid results in rapid shallow breathing and hypoxemia, heavy noncrepitant lungs, atelectasis, intraalveolar hemorrhage, interstitial edema, and hyaline membrane formation, satisfying many of the criteria for RDS (1, 8) . The animal model may vary from idiopathic RDS in lacking potential vascular shunts through the foramen ovale and ductus arteriosus.
MATERIALS A N D METHODS
Six mongrel dogs (18-25 kg) were anesthetized with sodium pentobarbital (25 mg/kg iv), followed by continuous infusion (up to 3.1 mg/kg/hr iv) in saline to maintain a constant level of' light anesthesia, characterized by maintenance of corneal reflexes and pupillary responses to light with absence of responses to sound or spontaneous movement of the extremities. The dogs breathed 100% oxygen spontaneously through a cuffed endotracheal tube (Portex, 11.5 mm ID) throughout the experiment.
The following measurements were made: 1) arterial pH, PaC02, and Paon on samples drawn from an indwelling femoral arterial catheter (Radiometer blood gas analyzer, model PHM 71); 2) mixed venous blood gases on samples drawn from the proximal lumen of a triple lumen Swan-Ganz catheter inserted through.the jugular vein into the pulmonary artery; 3) cardiac output (QT), determined by the Cardiogreen dye dilution technique (Waters densitometer; Harvard infusion/withdrawal pump, model 600-950V); 4) heart rate and systemic blood pressure (BP), using the femoral arterial catheter (Statham pressure transducer, model P23Db); 5) pulmonary artery and pulmonary wedge pressure After making initial measurements during spontaneous ventilation, three animals, before infusion of oleic acid, received 5, 10, 15, and 20 cm H 2 0 of CPAP in random order, each alternated with periods of zero end-expiratory pressure (0 CPAP). Measurements were made between 30 and 40 min after changing the amount of CPAP. All six animals then received oleic acid (0.225 mg/kg or 0.28 ml/kg) infused iv through the Swan-Ganz catheter. We used a dose of oleic acid adequate to decrease Pa02 to less than 70 mm Hg while animals breathed 100% oxygen. Physiologic saline solution was infused, 500 ml over the first 0.5 hr and approximately 1.5 liters over the remainder of the experiment. One hour was allowed for the preparation to stabilize in three experiments, and 5 hr in the other three. (Since no differences in responses were noted, all data were evaluated together.) Measurements were again made after the stabilization period and during administration of CPAP, similar to before oleic acid, although several measurements were made at each level of CPAP.
CPAP was administered by flowing 1Wo 0 2 continuously through a humidifier, across a Bourn's T-piece connected to the endotracheal tube, into a 6-liter reservoir bag with a retard valve at its distal end at 2-3 times the dog's spontaneous minute ventilation to avoid rebreathing (7) (Fig. I) . The retard valve was adjusted to set the end-expiratory pressure, which was monitored with a calibrated aneroid manometer.
In order to assess the effect of oleic acid infusion and the stability of the preparation without CPAP, measurements were made on all animals breathing spontaneously with 0 CPAP before oleic acid infusion and 1.5,5, 8, and 12 hr after oleic acid infusion. Statistical comparisons between mean values under different conditions were made using unmatched r-test. A level of P < 0.05 was considered to be significant.
RESULTS

EFFECTS OF OLElC ACID INFUSION
There was a statistically significant fall in arterial pH, PaOz, PCOZ, QT. Cdyn, and blood presure (Table 1 ) and a statistically significant increase in PaC02, VI, and PVR 1.5 hr after oleic acid infusion. Beyond the 1.5-hr period after oleic acid infusion, no parameters changed significantly during 0 CPAP periods throughout the remainder of the experiment, and therefore all values are reported together. Thus changes subsequently observed during CPAP could not be ascribed to time-related effects of oleic acid infusion.
EFFECrS OF CPAP
Values at each of the four levels of CPAP were compared with values at 0 CPAP. The mean PaC02 of 44.1 f 1.8 mm Hg during 0 CPAP rose progressively with increasing levels of CPAP to 77.6 * 6.8 mm Hg at 20 cm H20 CPAP (statistically significant at 10, 15, 20 cm H20 CPAP) (Fig. 2) . These increases reversed completely during the 30-min period of stabilization after CPAP was discontinued (Fig. 3) . Mean arterial pH decreased significantly at CPAP of 10, 15, and 20 cm H20, inversely to changes in PaC02 (Table 2) at 10, 15, and 20 cm H20) (Fig. 4) . Mean PC02 rose from 37.4 f 1.5 mm Hg at 0 CPAP to 60.8 f 3.1 mm Hg at 20 cm Hz0 CPAP (statistically significant at 10, 15, and 20 cm HzO) (Fig. 4) . Mean Q JQ, decreased with increasing CPAP, the change was statistically significant at 10, 15, and 20 cm Hz0 CPAP (Fig. 4) . Mean Vr decreased significantly at CPAP of 10, 15, and 20 cm Hz0 characterized by a decrease in VT (Fig. 5) .
Mean QT did not change significantly from 0 CPAP at any level of CPAP (Table 2 ). Changes in mean arterial blood pressure were statistically significant at 10, 15, and 20 cm Hz0 CPAP (Table 2) . Mean 0 2 delivery, whole blood lactate concentrations, Cdyn. and PVR did not change significantly from 0 CPAP at any of the levels of CPAP studied (Table 2 ).
In the three animals studied before oleic acid lung injury there was no significant difference between PaCOz values at 0 CPAP and at 5-20 cm H 2 0 (Fig. 2) . The respiratory pattern remained normal in contrast to the rapid shallow breathing observed in the animals after oleic acid lung injury (Fig. 5) .
DISCUSSION
Pa02 increased significantly during CPAP of 15 and 20 cm HzO, changes similar to those previously reported in clinical trials with CPAP in treatment of idiopathic RDS (2, (4) (5) (6) . Cardiac output did not fall significantly at any level of CPAP studied, in contrast to animal studies using continuous positive pressure breathing (CPPB) with similar levels of end-expiratory pressure in P I 0 2 are thought to reflect changes in tissue PO2 (16). The fact that whole blood lactate concentration did not change indicates that there was no significant redistribution of blood flow resulting in hypoperfusion of some tissues.
Significant findings not previously reported in clinical studies of effects of CPAP are the observations that hypercapnea proportional to the level of CPAP occurs during CPAP in a model of severe RDS, and that the increase in PaC02 is immediately reversible upon discontinuing CPAP.. During any level of CPAP in three animals before oleic acid infusion significant hypoventilation did not occur, indicating that hypoventilation does not occur with CPAP alone but only with the additive effect of oleic acid lung injury. The mechanisk of the difference has not been studied but is presumably related to the increased work of breathing after oleic acid injury. This could be related to changes in compliance and in respiratory rate and dead space ventilation.
Possible explanations for the hypercapnea after lung injury during CPAP include the following.
REBREATHING OF EXHALED Coy IN SEMICLOSED ANESTHESIA SYSTEM
Significant rebreathing from the anesthesia bag was unlikely, because O2 flow across the opening of the endotracheal tube was 2-3 times the animal's minute ventilation. In several animals flow rates of 0 2 were varied from 1-6 times the animal's minute ventilation without significantly affecting PaC02, suggesting that flow rates were not a factor in producing hypercapnea. Third, the carbon dioxide tension in the anesthesia bag was less than 8 mm Hg in all experiments, much less than the maximal changes in PaC02 observed, and could thereafter not possibly account for, more than a small fraction of the hypercapnea noted.
INCREASED WORK OF BREATHING
CPAP could potentially increase the work of breathing per unit alveolar ventilation by increasing lung volume and shifting ventilation to a higher portion of the pressure-volume curve, where compliance is lower, and by increasing anatomic dead space (13, 18) . However, measured dynamic compliance did. not change significantly at any level of CPAP. Furthermore, VI decreased with increasing CPAP, so that the work of breathing was not increased by an increase in volume of ventilation, raising the question of whether increasing PaC02 during CPAP could be related to the work of breathing. produce active expiration (3). Since under normal cond~t~ons the major respiratory work is inspiratory, the work of breathing might be increased during CPAP in spite of the fact that Cdyn did not change.
EFFECT ON STIMULATION O F PULMONARY REFLEXES
Since stretch receptor discharge has been reported to inhibit ventilation in normal dogs (15) by a direct effect on the respiratory center, it is possible that the increased airway pressure and/or lung volume during CPAP could depress ventilation by a direct effect of increasing stretch receptor activity on the respiratory center or by limiting VT (with unchanged f) due to increased stretch receptor stimulation during inspiration at higher lung volumes (exaggerated inspiratory-inhibitory reflex).
Lysons and Cheney (1 1) studied the effects of 5, 10, and 15 cm HzO positive end-expiratory pressure in dogs before and after oleic acid lung injury, breathing 10Wo oxygen spontaneously through a nonrebreathing valve with its expiratory line immersed under water. Although their system differed from ours in that positive airway pressure was not applied during the entire respiratory cycle, the effects on PaOz, PfOz, PaC02, and shunt fraction were similar. Lysons' mean PaCOz before lung injury was 55 & 4 mm Hg, as compared to our mean of 39 + 2 mm Hg. The lower PaCOz in our study may have resulted from the inspiratory assist of our system. Their results differed from ours prior to oleic acid injury in that there was a significant increase in PaCOz at 15 cm Hz0 only, and a decreased respiratory rate at 5, 10, and 15 cm HzO. The rise in PaCOz at 15 cm HzO in Lysons' experiments might be because ventilatory loading has a greater effect on PaC02 the greater the initial PaCO* and presumed respiratory depression (unpublished observations, this laboratory).
In Lysons' study following oleic acid lung injury cardiac index fell significantly at 15 cm Hz0 and respiratory rate fell significantly at all levels of CPAP with no significant change in VT, in contrast to our study in which there was no change in cardiac output and a significant fall in f only at 10 cm HzO and a significant fall in VT at 10, 15, and 20 cm H20. There is no clear explanation for the differences between our results and those of Lysons with respect to f o r VT before or after lung injury. Our animals received almost double the oleic acid dose of Lysons' (0.15 ml/kg), and with zero end-expiratory pressure our animals had a mean Pa02 of 63.6 It 3.1 mm Hg, as compared to 95 f 13 mm Hg in Lysons' experimental group. The more severe lung injury and resultant greater hypoxemia in our group may have stimulated ventilation or changed pulmonary reflexes activity.
